Quantcast

Latest Peripheral vascular disease Stories

2011-06-21 02:01:37

Millions of adults with peripheral artery disease are not receiving the medications needed to reduce their risk of heart attack, stroke and death, according to research in Circulation: Journal of the American Heart Association. Most patients are not receiving recommended therapies such as cholesterol and blood pressure-lowering medications, the study's authors found. Peripheral artery disease is the result of atherosclerosis, or blockages in the arteries in the legs caused by plaque. People...

2011-06-20 19:47:07

Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents, according to a study presented at the late-breaking clinical trials session of the Vascular Annual Meeting in Chicago on June 18, 2011. For the estimated 8 million people in the United States with peripheral artery disease (PAD) and for their physicians, the new findings may prove useful in weighing treatment...

2011-06-20 07:30:00

NATICK, Mass., June 20, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Mustang(TM) PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The Company plans to launch the product immediately in the U.S., Europe and other international markets. Boston Scientific developed the Mustang PTA Balloon Catheter to meet...

2011-06-13 08:59:00

MONTREAL, June 13, 2011 /PRNewswire/ -- Researchers today announced the results of a study that show echocardiography can improve the success rate of gene therapy and increase growth, function and sustainability of regenerated vessels. The study will be presented at the American Society of Echocardiography (ASE) 22nd Annual Scientific Sessions, June 11-15, 2011. "This study showed that echo-mediated gene therapy will be beneficial for individuals suffering from chronic vascular...

2011-05-04 15:07:00

SAN DIEGO, May 4, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), the leading developer and manufacturer of precision guided therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced the signing of a supply agreement with ev3, a Covidien company, under which Volcano will supply its proprietary Intravascular Ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems. Utilizing the digital IVUS transducer incorporated...

2011-05-04 13:21:46

Peripheral arterial disease (PAD) is an indicator for coronary and carotid arterial disease and carries inherent risks of claudication and amputation. PAD screening has increased dramatically, particularly among cardiologists, while vascular surgery has demonstrated the greatest growth in revascularization procedures treating PAD, according to research being presented at the 2011 American Roentgen Ray Society's annual meeting. The study was performed at Rhode Island Hospital in Providence,...

2011-04-25 08:00:00

CHICAGO, April 25, 2011 /PRNewswire-USNewswire/ -- Nearly 1,200 experts in cardiovascular medicine, vascular biology, endocrinology, hematology and other disciplines are expected to attend the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2011 Scientific Sessions, April 28-30, in Chicago, Ill. The conference will include nearly 700 abstracts, plus about 100 invited oral presentations, representing a breadth of research on vascular biology and...

2011-04-14 07:00:00

WEBSTER, Texas, April 14, 2011 /PRNewswire/ -- The Medical Devices Bureau of Health Canada has granted regulatory approval for the SUPERA VERITAS stent system for use in biliary and peripheral procedures. IDEV's unique stent was previously available on a limited basis only, through the Special Access Program. Christopher Owens, President and CEO of IDEV, commented, "With the full regulatory approval that has been granted we can immediately launch SUPERA VERITAS throughout Canada. Based...

2011-03-24 13:09:00

New DMC Cardiovascular Institute technique restores blood flow to lower limbs DETROIT, March 24, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation. The innovative new procedure is aimed at greatly reducing the need for lower-limb amputations by restoring interrupted blood-flow to...

2011-03-10 14:00:00

MINNEAPOLIS, March 10, 2011 /PRNewswire/ -- BridgePoint Medical, Inc., a private company developing innovative and proprietary technology in the field of interventional cardiology for crossing coronary and peripheral chronic total occlusions (CTO), announced today that it has completed its third round of financing earlier this year, totaling $9.1 million. The round was lead by a new strategic investor and joined by existing investors New Enterprise Associates, Polaris Venture Partners,...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related